Dementia‐related adverse events in PARADIGM‐HF and other trials in heart failure with reduced ejection fraction-Reference-Cited by-同舟云学术

Dementia‐related adverse events in PARADIGM‐HF and other trials in heart failure with reduced ejection fraction

Published:2016-11-20 Issue:1 Volume:19 Page:129-137
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Cannon Jane A.¹,Shen Li¹,Jhund Pardeep S.¹,Kristensen Søren L.²,Køber Lars²,Chen Fabian³,Gong Jianjian³,Lefkowitz Martin P.³,Rouleau Jean L.⁴,Shi Victor C.³,Swedberg Karl⁵,Zile Michael R.⁶,Solomon Scott D.⁷,Packer Milton⁸,McMurray John J.V.¹,

Affiliation:

1. BHF Cardiovascular Research Centre University of Glasgow Glasgow UK

2. Rigshospitalet Copenhagen University Hospital Copenhagen

3. Novartis Pharmaceutical Corporation East Hanover NJ USA

4. Institut de Cardiologie Université de Montréal Montréal Canada

5. Department of Molecular and Clinical Medicine University of Gothenburg, Gothenburg, Sweden and National Heart and Lung Institute, Imperial College London

6. Medical University of South Carolina and RHJ Department of Veterans Administration Medical Center Charleston SC USA

7. Cardiovascular Medicine, Brigham and Women's Hospital Boston MA USA

8. Baylor Heart and Vascular Institute Baylor University Medical Center Dallas TX USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.687

Reference25 articles.

1. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

2. Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure